[1]
Tutar L, Ozgur A, Tutar Y. Involvement of miRNAs and Pseudogenes in Cancer. Methods in molecular biology (Clifton, N.J.). In book. MicroRNA and Cancer 2018; 1699: 45-66.
[2]
Gurer DC, Akgul B. Noncoding RNAs: A New Layer of Functional RNAs. Curr Pharm Biotechnol 2023; 24(7): 856-71.
[http://dx.doi.org/10.2174/1389201023666220602102133]
[http://dx.doi.org/10.2174/1389201023666220602102133]
[3]
Allmer J. Noncoding RNA Databases. Curr Pharm Biotechnol 2023; 24(7): 825-31.
[http://dx.doi.org/10.2174/1570180819666220520124511]
[http://dx.doi.org/10.2174/1570180819666220520124511]
[4]
Siafaka PI, Çağlar EŞ, Gündoğdu EA, Okur NÜ. New era on combining both Imaging and drug delivery to treat Cancer. Curr Pharm Biotechnol 2023; 24(7): 832-56.
[http://dx.doi.org/10.2174/1389201023666220617152334]
[http://dx.doi.org/10.2174/1389201023666220617152334]
[5]
Erdoğan İ, Sweef O, Akgül B. Long Noncoding RNAs in Human Cancer and Apoptosis. Curr Pharm Biotechnol 2023; 24(7): 872-89.
[http://dx.doi.org/10.2174/1389201023666220624094950]
[http://dx.doi.org/10.2174/1389201023666220624094950]
[6]
Çetinkaya B, Baran Y. MicroRNAs and Long Non-coding RNAs as Novel Targets in Anti-cancer Drug Development. Curr Pharm Biotechnol 2023; 24(7): 913-25.
[http://dx.doi.org/10.2174/1389201023666220803150431]
[http://dx.doi.org/10.2174/1389201023666220803150431]
[7]
Coskun KA, Kıyak BY, Cifci KU, Kadioglu E, Yurekli N, Tutar Y. Involvement of Metabolites and Non-coding RNAs in Diseases. Curr Pharm Biotechnol 2023; 24(7): 889-912.
[http://dx.doi.org/10.2174/1389201023666220921091240]
[http://dx.doi.org/10.2174/1389201023666220921091240]
[8]
Sun YM, Chen YQ. Principles and innovative technologies for decrypting noncoding RNAs: from discovery and functional prediction to clinical application. J Hematol Oncol 2020; 13(109)
[9]
Tutar L, Tutar E, Tutar Y. MicroRNAs and cancer; an overview. Curr Pharm Biotechnol 2014; 15(5): 430-7.
[http://dx.doi.org/10.2174/1389201015666140519095304]
[http://dx.doi.org/10.2174/1389201015666140519095304]